Waters Corporation Stock (WAT) - Quote Nyse- MarketScreener

Waters Corporation Stock

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-05-30 pm EDT 5-day change 1st Jan Change
307.6 USD -6.11% Intraday chart for Waters Corporation -8.66% -6.56%
Sales 2024 * 2.97B Sales 2025 * 3.15B Capitalization 18.25B
Net income 2024 * 637M Net income 2025 * 719M EV / Sales 2024 * 6.59 x
Net Debt 2024 * 1.31B Net Debt 2025 * 1.1B EV / Sales 2025 * 6.14 x
P/E ratio 2024 *
30.3 x
P/E ratio 2025 *
26.7 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.11%
1 week-8.66%
Current month-0.46%
1 month-0.46%
3 months-11.10%
6 months+9.63%
Current year-6.56%
More quotes
1 week
299.02
Extreme 299.0201
339.33
1 month
299.02
Extreme 299.0201
367.21
Current year
288.94
Extreme 288.94
367.21
1 year
231.90
Extreme 231.9
367.21
3 years
231.90
Extreme 231.9
428.22
5 years
154.39
Extreme 154.39
428.22
10 years
93.56
Extreme 93.56
428.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 20-08-31
Director of Finance/CFO 48 21-05-11
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 65 18-08-31
Director/Board Member 68 23-03-26
Director/Board Member 70 06-04-30
More insiders
Date Price Change Volume
24-05-30 307.6 -6.11% 977,873
24-05-29 327.6 -1.26% 411,804
24-05-28 331.8 -1.37% 389,273
24-05-24 336.5 -0.10% 458,674
24-05-23 336.8 -3.44% 787,508

Delayed Quote Nyse, May 30, 2024 at 04:00 pm EDT

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
327.6 USD
Average target price
326 USD
Spread / Average Target
-0.50%
Consensus